Edesa Biotech Inc
EDSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$33.81M
Close$
$1.90
28.8% downside
Current Fair Value
28.8% downsideOvervalued by 28.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $33.81 Million |
|---|---|
| Enterprise Value | $23.48 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.27 |
| Beta | 1.06 |
| Outstanding Shares | 9,007,000 |
Return
| Return on Equity | -110.85% |
|---|---|
| Return on Assets | -110.85% |
| Return on Invested Capital | -162.31% |
Valuation & Multiples
| P/E Ratio | -2.08 |
|---|---|
| PEG | -0.99 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 461.14 |
| Enterprise Value to EBIT | -1.64 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 11, 2026
EPS Estimate
$-0.58
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 41.68%▲ 10.73% |
|---|---|
| Total Invested | $30.00M▲ 117.01% |
| Investors Holding | 34▲ 7.00% |
ESG Score
No data